Thrasos Therapeutics, Inc. is a biotechnology company developing unique therapeutic agents to prevent and treat severe organ failure and other critical medical needs. The Company’s drug candidates are proprietary small molecules that selectively activate the key receptors of the bone morphogenetic protein family. Thrasos is developing its first drug candidates for the treatment and prevention of Acute Kidney Injury and Chronic Kidney Disease.

©2009 Thrasos Therapeutics. All rights reserved.